Nasal immune cell spray tested in women for first time
Knowledge-focused
Completed
This early-stage trial tested whether a nasal spray containing memory T cells from male donors is safe for healthy women aged 18–55. Nine participants received the spray and were monitored for side effects. The goal was to find the highest safe dose, not to treat any disease.
Phase: PHASE1 • Sponsor: Cristina Calvo Rey • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:58 UTC